No surprise after the disaster of the three major US stock indexes ugly closes Friday to finish off a disastrous September and the IPO market there are currently no IPOs scheduled for the first week of October. The biggest news of the week came from Intel’s Mobileye (MBLY), which filed for an IPO we estimate could raise up to $2.5 billion. The third quarter was worst third quarter for new issuers in over a decade, with 25 IPOs raising $2.4 billion as … Continue reading “US Weekly IPO and SPAC Monitor: Intel’s Mobileye Filed for an IPO in Quiet Period”
US Weekly IPO and SPAC Monitor: Biotech Intensity Therapeutics, Chinese YanGuFang and Japanese Lead Real Estate
Coming into end of quarter IPO pricing expect from two Asian issuers and a biotech. Chinese producer of oat and grain products YanGuFang (YGF), Japanese luxury real estate developer Lead Real Estate (LRE) and Oncology biotech Intensity Therapeutics (INTS). There may also be a number of small deals that have been expected but have not priced. Another quiet week as IPO continue to dry up in this risk off market. One NYSE American uplisting Loop Media (LPTV) priced at the … Continue reading “US Weekly IPO and SPAC Monitor: Biotech Intensity Therapeutics, Chinese YanGuFang and Japanese Lead Real Estate”
Cano Health Shares Soar on Humana and CVS Buyout Rumors
Primary care provider Cano Health’s stock rose sharply late Thursday, $CANO soared over 50% after WSJ reported Humana (HUM) and CVS Health (CVS) and other possible suitors are hovering with a possible deal in the next several weeks citing sources familiar with the negotiations. Bloomberg reported separately that Cano is working with financial advisers and CVS is weighing a potential bid. Last month Owl Creek Asset Management, which owns a 3.75% stake of 8.69 million shares urged the company to … Continue reading “Cano Health Shares Soar on Humana and CVS Buyout Rumors”
US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics
The IPO issuance slows down in the week ahead after AIG spin Corebridge Financial (CRBG) was the biggest IPO of 2022 thus far. Three small deals may price in the week ahead, Neuro-inflammation biotech Jupiter Neurosciences (JUNS) is the largest. Two nano-caps may price in the week ahead, infectious disease biotech Alopexx (ALPX) and laser-based system maker Laser Photonics (LASE). Last week six issuers began trading, AIG spin-off Corebridge $CRBG, the largest deal of 2022. Third Harmonic Bio (THRD) upsized, Nexalin Technology (NXL) … Continue reading “US Weekly IPO and SPAC Monitor: Biotechs Jupiter Neurosciences and Alopexx with Laser Photonics”
US Weekly IPO and SPAC Monitor: AIG spin-off Corebridge, Third Harmonic Bio and LINKBANCORP
AIG spin-off Corebridge $CRBG, in what could be the largest deal of 2022 so far, plans to raise $1.8 billion at a fully diluted market value of $14.7 billion-week next week. Six other deals are expected to begin trading in the week ahead including biotech Third Harmonic Bio (THRD), China based Lichen China (LICN), neurostimulation medical device maker Nexalin Technology (NXL) and non-invasive neural input technology company Wearable Devices (WLDS). Two companies are planning to up list from the OTC. Pennsylvania-based The Gratz Bank LINKBANCORP (LNKB) and Bio- … Continue reading “US Weekly IPO and SPAC Monitor: AIG spin-off Corebridge, Third Harmonic Bio and LINKBANCORP”
Smart Safety Syringes Maker Sharps Technology Closes Initial Public Offering
Medical device company Sharps Technology announced the closing of its initial public offering at $4.25 on Friday. The company has patented, best-in-class, single use smart safety syringe products. The common stock and warrants began trading on The Nasdaq Capital Market under the symbols “STSS” and “STSSW,” respectively. Sharps Provensa™ is their premier line of smart safety syringes. The firm says that offer solutions to global healthcare crises such as the 1-2 billion syringe shortage forecasted by the World Health Organization (WHO) … Continue reading “Smart Safety Syringes Maker Sharps Technology Closes Initial Public Offering”
US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.
Coming into Year end the IPO market is winding down. This week we have just four IPOs scheduled to raise around $50 million for the week. Cerberus Cyber Sentinel (CISO), Incannex Healthcare (IXHL), Intensity Therapeutics (INTS) and Nuvo Group (NUVO) are expected to debut this week. Cerberus Cyber Sentinel (CISO) Cerberus Cyber Sentinel (CISO) based in Scottsdale, Arizona plans to raise $10 million priced at $5 for a $631 million market cap. The company provides a range of cybersecurity consulting and related services, … Continue reading “US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.”
US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads
Coming into Year end the IPO market is winding down. This week we have four IPOs scheduled to raise $814 million for the week. IoT solutions developer (IOT) Samsara, CNS biotech Bionomics (BNOX), Fresh Vine Wine (VINE) and Satellite developer Sidus Space (SIDU) are all expected to debut this week. IoT solutions developer Samsara (IOT) Samsara plans to raise $753 million at an $11.6 billion market cap. Samsara is a developer of end-to-end Internet of Things solutions for businesses and provides a cloud-based platform. The … Continue reading “US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads”
US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead
Following the Thanksgiving lull the IPO market is expected to pick up with four IPOs scheduled to raise $3.7 billion for the week. Chicago Atlantic Real Estate Finance (REFI) Cloud infrastructure platform HashiCorp (HCP) Austin Gold (AUST) and Buffett-backed Nu Holdings (NU) debut. Cloud infrastructure platform HashiCorp (HCP) Plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and … Continue reading “US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead”
F.D.A. Antimicrobial Drugs Panel Endorse Merck’s Covid Pill Molnupiravir For High Risk Adults.
The Food and Drug Administration Antimicrobial Drugs Advisory Committee Meeting voted on Tuesday to recommend authorizing the molnupiravir Covid pill from Merck for high-risk adults. It would be the first in a new class of antiviral drugs that could work against a wide range of variants, including Omicron. Molnupiravir has been shown to modestly reduce the risk of hospitalization and death, predominantly from the Delta, Mu and Gamma variants. The expert panel recommended it for Covid patients who are older … Continue reading “F.D.A. Antimicrobial Drugs Panel Endorse Merck’s Covid Pill Molnupiravir For High Risk Adults.”